This webinar provided a robust analysis of important drug modalities including JAK inhibitors, TNF alphas, and S1P modulators, a review of recent drug approvals, discontinuations, and trial-reported adverse events, and market insights surrounding the latest trends, factors driving growth and leading players in the IBD sectors. Watch the recording now.
Webinar Leaders
House Speaker
Rachel Hourigan
Research Analyst
Beacon
House Speaker
Joseph Moss
Senior Market Analyst
Hanson Wade Intelligence
Moderator
Farrah Vogel-Javeri
Scientific Liaison Analyst
Beacon
Speak with industry experts
What is Beacon Immune Tolerance?
Beacon Immune Tolerance covers all pharmaceutical interventions used to treat autoimmune diseases, autoinflammatory diseases, alloimmune diseases and allergies.
From small molecules to CAR T therapy, the module encapsulates all drugs and therapies within the immune-mediated disease space.
New data expansion: Deals and Companies. Gain unparalleled access to in-depth company profiles and the latest commercial deals. Monitor your competitors and opportunities as well as benchmark deals and evaluate potential partners. Learn more about Deals and Companies data by downloading the factsheet.
Who are Hanson Wade Intelligence?
Outsource your competitive intelligence to Hanson Wade Intelligence and have our analysts support your market landscaping and competitive benchmarking.
Hanson Wade Intelligence are modality experts with multi-project experience in preclinical and clinical evaluation of ADCs, Cell and Gene Therapy, RNA, Protein Degraders and much more. With strong primary and secondary research skills, Hanson Wade Intelligence is ideally positioned to be your CI partner.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
